• Je něco špatně v tomto záznamu ?

Propolis-induced hepatorenoprotection in rodents exposed to rifampicin and isoniazid

Ahmed Abdulsallam, Imad A. Thanoon, Abdulrahman I. Abduljabbar

. 2023 ; 92 (1) : 75-86. [pub] 20230303

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc23000953

The elimination of most drugs based on liver/renal excretion; making liver and kidneys the commonest target organ for exposure to toxic materials. Long-term use of drugs surpassed the effect and aggravate the toxicity. Tuberculosis (TB) is chronic disease with long-term therapy and the deleterious impact of antitubelculosis is certain. Various pharmacokinetic manoveuors were proposed to avoid the potential harmful effect of TB therapy. The present study aimed at mitigating the destructive effects of TB therapy using propolis. To do so, rats were exposed to isoniazid or rifampicin or a combination of them in groups of 8 rats each for a period of 8-weeks these groups were matched with similar group with a propolis ad-on therapy. These results were compared to propolis-free negative control group and positive propolis-treated group. The histological and laboratory findings confirmed that isoniazid or rifampicin or a combination of them jeopardized hepatorenal function and induced deleterious damage. However, isoniazid has shown more intensive deleterious effect compared to rifampicin. Nonetheless, propolis restore the quasi-equilibrium status for kidney and liver via restoring its normal architecture and functionality. To sum up, the potential defect of anti-TB was restored via using propolis as add-on therapy, we do advise using propolis as an adjuvant TB therapy in critically-ill and clinical cases required long-term TB therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23000953
003      
CZ-PrNML
005      
20230402000641.0
007      
ta
008      
230307s2023 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.31482/mmsl.2022.026 $2 doi
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Abdulsallam, Ahmed $u Alkhansaa Teaching hospital, Mosul, Ninevah Province, Iraq
245    10
$a Propolis-induced hepatorenoprotection in rodents exposed to rifampicin and isoniazid / $c Ahmed Abdulsallam, Imad A. Thanoon, Abdulrahman I. Abduljabbar
520    9_
$a The elimination of most drugs based on liver/renal excretion; making liver and kidneys the commonest target organ for exposure to toxic materials. Long-term use of drugs surpassed the effect and aggravate the toxicity. Tuberculosis (TB) is chronic disease with long-term therapy and the deleterious impact of antitubelculosis is certain. Various pharmacokinetic manoveuors were proposed to avoid the potential harmful effect of TB therapy. The present study aimed at mitigating the destructive effects of TB therapy using propolis. To do so, rats were exposed to isoniazid or rifampicin or a combination of them in groups of 8 rats each for a period of 8-weeks these groups were matched with similar group with a propolis ad-on therapy. These results were compared to propolis-free negative control group and positive propolis-treated group. The histological and laboratory findings confirmed that isoniazid or rifampicin or a combination of them jeopardized hepatorenal function and induced deleterious damage. However, isoniazid has shown more intensive deleterious effect compared to rifampicin. Nonetheless, propolis restore the quasi-equilibrium status for kidney and liver via restoring its normal architecture and functionality. To sum up, the potential defect of anti-TB was restored via using propolis as add-on therapy, we do advise using propolis as an adjuvant TB therapy in critically-ill and clinical cases required long-term TB therapy.
650    17
$a krysa rodu Rattus $7 D051381 $2 czmesh
650    17
$a propolis $x farmakologie $7 D011429 $2 czmesh
650    _7
$a rifampin $x antagonisté a inhibitory $x škodlivé účinky $7 D012293 $2 czmesh
650    _7
$a isoniazid $x antagonisté a inhibitory $x škodlivé účinky $7 D007538 $2 czmesh
650    _7
$a antituberkulotika $x antagonisté a inhibitory $x škodlivé účinky $7 D000995 $2 czmesh
650    _7
$a nežádoucí účinky léčiv $x farmakoterapie $x terapie $7 D064420 $2 czmesh
650    _7
$a modely u zvířat $7 D023421 $2 czmesh
650    _7
$a nemoci jater $x prevence a kontrola $7 D008107 $2 czmesh
650    _7
$a nemoci ledvin $x prevence a kontrola $7 D007674 $2 czmesh
650    _7
$a biochemická analýza krve $x metody $x přístrojové vybavení $7 D001774 $2 czmesh
650    _7
$a biomedicínský výzkum $7 D035843 $2 czmesh
650    _7
$a histologické techniky $7 D006652 $2 czmesh
650    _7
$a mikroskopie $7 D008853 $2 czmesh
651    _7
$a Irák $7 D007493 $2 czmesh
700    1_
$a Thanoon, Imad A. $u College of Medicine, University of Mosul, Mosul, Ninevah Province, Iraq
700    1_
$a Abduljabbar, Abdulrahman I. $u Graduated Physician, University of Mosul, Mosul, Ninevah Province, Iraq
773    0_
$t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 92, č. 1 (2023), s. 75-86 $w MED00011116
856    41
$u https://mmsl.cz/artkey/mms-202301-0009_propolis-induced-hepatorenoprotection-in-rodents-exposed-to-rifampicin-and-isoniazid.php $y plný text volně přístupný
910    __
$a ABA008 $b A 3 $c 1073 $y p $z 0
990    __
$a 20230307 $b ABA008
991    __
$a 20230402000633 $b ABA008
999    __
$a ok $b bmc $g 1907480 $s 1187148
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2023 $b 92 $c 1 $d 75-86 $e 20230303 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
LZP    __
$c NLK189 $d 20230402 $b NLK111 $a Actavia-MED00011116-20230307

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...